ALB and Sepsis: In comparison, the ALBIOS study investigators looked at the effect of hyperoncotic albumin in patients with severe sepsis and septic shock and did not find any difference in either mortality as the primary outcome or in severe AKI, defined as a creatinine level >300 μmol/L [12].